Evidence map›Paper›PMID 41495286›Full record

ArticleScientific reports2026

Utilizing fractional-order operator to Alzheimer's disease dynamics.

Kottakkaran Sooppy Nisar, Muhammad Farman

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kottakkaran Sooppy NisarDepartment of Mathematics, College of Science and Humanities in Al Kharj, Prince Sattam bin Abdulaziz University, Al Kharj, Saudi Arabia. n.sooppy@psau.edu.sa.
Muhammad FarmanDepartment of Mathematics, Mathematics Research Center, Near East University, Nicosia, 99138, Cyprus, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fractional derivative modeling has become an important tool for studying and forecasting disease transmission dynamics. We propose a new mathematical model for Alzheimer’s disease, a condition in which dying and malfunctioning neurons impair memory. The model has a five-dimensional set of nonlinear fractional differential equations for microglia, amyloid-beta, tau protein, infected neurons, and functioning neurons. To further understand the dynamics of the proposed model, we demonstrated the solutions’ existence, uniqueness, positivity, and feasible domain. We used the next-generation technique to calculate the fundamental reproduction number [Formula: see text], the threshold parameter of Alzheimer’s disease transmission. Two model equilibrium points have been found. The reproductive number parameters are subjected to sensitivity analysis in order to show how [Formula: see text] responds to parameter changes. The Ulam-Hyers-Rassias stability requirements have been confirmed. The suggested model is solved using the Newton polynomial interpolation method with the discretization of the Caputo fractional-order operator. Lastly, simulations are made to investigate the potential effects of factors that prevent the incidence of Alzheimer’s disease. The findings show how the proposed method may be able to provide deeper and possibly accurate predictions for the dynamics of Alzheimer’s disease, thus leading to more successful public health campaigns.

Indexed as

Alzheimer DiseaseModels, TheoreticalAmyloid beta-PeptidesComputer SimulationHumansMicrogliaNeuronstau ProteinsAmyloid beta-Peptidestau ProteinsAlzheimer’s diseaseCaputo operatorFractional-order modelSensitivity of parametersULAM-Hyers-Rassias stability

Identifiers

PMID41495286
PMCPMC12852127

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.